SEC Form D filing

Lyora Therapeutics, Inc.

Biotech · Seed · Regulation D 506(b) · MA · Filed March 11, 2025

Offering amount: $2.0M
Exemption: Reg D 506(b)
Issuer state: MA
Filing date: March 11, 2025
Signature date: March 8, 2025
CIK: 0002058969

Public filing directories

Browse directories that group public SEC Form D records by the same filing tags shown on this page. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.

Sector: Biotech Month: March 2025 Stage and month: Seed

Summary

Auto-generated

Lyora Therapeutics biotech with $2M offering at seed/series-a boundary.

Generated automatically by a language model from the public SEC filing; may contain errors. Verify against the source document on EDGAR. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.

Source

View on SEC EDGAR →Get alerts for filings like this →

FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.